In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) ...

Shanghai Ark Biopharmaceutical (ArkBio) has concluded enrolment and dosing for a Phase I trial of fully human monoclonal ...

Respiratory virus activity remained low in the United States last week, with COVID levels continuing to decline, but ...

As family members gather at each other's houses this holiday season, illness might tag along. Here's what you need to know ...

The oral presentation "Novel Ligand-Targeted Immunotherapy for the Treatment of Human Respiratory Syncytial Virus (RSV)" ...

New COVID-19 research uncovers viral behavior insights, driving innovative treatments with Northwestern Medicine's support.

A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than ...

(“ArkBio”) announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a ...

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

A flock of geese taking off on a flooded out field at the Lower Klamath National Wildlife Refuge on Nov. 1, 2023. A strain of bird flu circulating in California has infected thousands of cattle and ...